Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Antipsychotic drug dropped from Novartis pipeline

Nov. 25, 1998

Lilly's new glutamate receptor antagonists for pain

Nov. 25, 1998

Central alpha2-adrenoceptor antagonists claimed by Janssen for depression, Parkinson's disease

Nov. 25, 1998

Dopamine D3 receptor antagonists may provide clues about receptor function

Nov. 25, 1998

Tasmar sales suspended in Canada

Nov. 24, 1998

Synapton NDA is nonapprovable, FDA says

Nov. 24, 1998

Substituted heteroaromatic 5-ht1f agonists in development at Lilly as antimigraine agents

Nov. 24, 1998

Novel CRF1-specific ligands claimed by Neurogen

Nov. 24, 1998

Pyridazine and phthalazine derivatives from SmithKline Beecham for CNS, neurological disorders

Nov. 24, 1998

Dual 5-HT reuptake inhibitor/5-HT1A antagonist discussed at neuroscience meeting

Nov. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...